Home > Boards > US Listed > Medical - Drugs >

Nektar Therapeutics (NKTR)

Add NKTR Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 3/1/2019 9:42:01 AM - Followers: 38 - Board type: Free - Posts Today: 0



Nektar Therapeutics, a biopharmaceutical company, develops various drug products and product candidates using its proprietary drug delivery technologies. Its technology platforms comprise PEGylation Technology designed to enhance the performance of various drug classes, including macromolecules, small molecules, and other drugs; and Pulmonary Technology, which includes technologies for drug formulation, powder processing, powder filling, and packaging, as well as dry powder inhaler devices and liquid nebulizer devices. The company's technologies are used in 10 approved products; 3 partner programs that have been filed for with the FDA; and 12 development programs in human clinical trials. Its partnered products include Tobramycin inhalation powder, a Phase III clinical product for treating lung infections; NKTR-061, a Phase II clinical product for gram-negative pneumonias; Ciprofloxacin Inhalation Powder, a Phase II clinical product for lung infections; Pulmonary dronabinol, a Phase II product for migraine; and Exubera Inhalation Powder for adult type 1 and type 2 diabetes. The company's partnered product portfolio also comprises Neulasta for neutropenia; PEGASY for Hepatitis-C; Somavert for Acromegaly; PEG-INTRON for Hepatitis-C; Macugen for age-related macular degeneration; CIMZIA for Crohn's disease; MIRCERA for renal anemia and chronic kidney disease; CIMZIA for rheumatoid arthritis; Hematide, a Phase III product for Anemia; Macugen, a Phase II clinical trial product for diabetic macular edema and retinal vein occlusion; and CDP 791, a Phase II product for nonsmall cell lung cancer. In addition, Nektar's proprietary products include NKTR-102, a Phase II trial product for colorectal cancer; and NKTR-118, which is in Phase II clinical trials for opioid-induced constipation and other manifestations of opioid bowel dysfunction. The company was founded in 1990 and is headquartered in San Carlos, California.

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NKTR News: Nektar Therapeutics Presents Preclinical Data on its Immuno-Oncology Pipeline Candidates at the American Association for Canc... 04/02/2019 03:00:00 PM
NKTR News: Vaccibody AS and Nektar Therapeutics Present New Preclinical Data from their Immuno-Oncology Collaboration at the American As... 04/01/2019 04:15:00 PM
NKTR News: Statement of Changes in Beneficial Ownership (4) 03/12/2019 06:19:06 PM
NKTR News: Nektar Therapeutics to Webcast Presentation at the Cowen and Company 39th Annual Health Care Conference 03/06/2019 04:30:00 PM
NKTR News: Detailed Research: Economic Perspectives on Canopy Growth, Aimmune Therapeutics, Nektar Therapeutics, Workday, Workiva, and M... 03/05/2019 08:15:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#238   NKTR 4Q18 CC transcript: DewDiligence 03/01/19 09:42:01 AM
#237   ASCO-SITC Clinical Immuno-Oncology Symposium abstract jondoeuk 02/25/19 05:35:40 PM
#236   Dr. Zalevsky will provide updates on NKTR-214 during jondoeuk 12/29/18 03:43:05 PM
#235   From this: ''With NKTR-214, a kinetically engineered IL-2 jondoeuk 11/25/18 03:58:37 PM
#234   SITC data—Melanoma PIVOT-02 ORR=53%* (20*/38)—24% (9/38) CRs: DewDiligence 11/09/18 06:46:10 PM
#233   I had a few too many. What I jondoeuk 11/08/18 12:30:16 PM
#232   NKTR 3Q18 results—cash=$2.0B: DewDiligence 11/07/18 06:45:02 PM
#231   NKTR 3Q18 results—cash=$353M: DewDiligence 11/07/18 04:41:37 PM
#230   NKTR, PFE ink clinical-trial collaboration for NKTR-214 with DewDiligence 11/06/18 09:29:43 AM
#229   You own ONCS because of management? DewDiligence 11/03/18 06:42:21 PM
#228   $GNCA*, $ONCS*, $GRTS, $REPL, $DVAX, $ADRO** and $IDRA*** jondoeuk 11/03/18 06:25:34 PM
#226   Which biotech companies are you long? TIA DewDiligence 10/27/18 06:40:01 PM
#225   Melanoma Bridge Conference: 'Immune monitoring after NKTR-214 plus jondoeuk 10/27/18 06:14:43 PM
#224   Appears that institutions have made up their mind tigerpac 10/24/18 11:47:29 AM
#223   On second thought, #msg-144383492 is a better explanation DewDiligence 10/22/18 04:01:52 PM
#222   My take, FWIW: #msg-144374334. DewDiligence 10/22/18 11:24:28 AM
#221   The shareholder is always the last one to tigerpac 10/22/18 11:16:57 AM
#220   After examining the "rebuttal" text more closely, I'm DewDiligence 10/04/18 08:30:55 PM
#219   If that's a real email response from the DewDiligence 10/04/18 03:09:32 PM
#218   Someone emailed the IR department and posted the jondoeuk 10/04/18 10:34:45 AM
#217   3 different posters on the NKTR YMB "Conversations" stockbettor 10/04/18 09:22:13 AM
#216   Where is that from? DewDiligence 10/03/18 06:58:23 PM
#215   This is the company's response to the short jondoeuk 10/03/18 03:46:04 PM
#214   Related info: #msg-136150360. DewDiligence 09/27/18 07:29:14 PM
#213   A neoantigen vaccine (VB10.NEO) and 214 will be jondoeuk 09/27/18 06:52:50 PM
#212   15% drop this week. Me thinks something not tigerpac 09/14/18 10:11:59 AM
#211   The CC was routine. A lot of clinical DewDiligence 08/10/18 10:30:52 AM
#210   Nothing negative from last earning report....stock back on tigerpac 08/10/18 09:48:27 AM
#208   No I sold awhile back because of so starkd748 06/05/18 07:41:42 AM
#207   Think you're better than me? seppi08162 06/05/18 06:40:54 AM
#206   I had this glad I took my profits starkd748 06/05/18 12:57:15 AM
#205   Nope. Lower she goes dipANDrip 06/04/18 02:25:41 PM
#204   Wanting to test LOD here. Will it hold? dipANDrip 06/04/18 02:01:52 PM
#203   21,000,000 plus shares traded and counting. Phoenix300 06/04/18 01:36:18 PM
#202   Most of the concerns are based upon a tigerpac 06/04/18 10:19:49 AM
#201   NKTR getting hammered pre-market Phoenix300 06/04/18 08:49:44 AM
#200   Some questions/concerns raised over this data released for seppi08162 06/03/18 12:15:42 PM
#199   Nice move today Phoenix300 06/01/18 08:17:17 PM
#198   long time without any momentum... this is a seppi08162 05/25/18 02:22:29 PM
#197   This means BMY can now start enrolling patients DewDiligence 04/04/18 01:33:09 PM
#196   It's official... tigerpac 04/03/18 06:19:07 PM
#195   On 3/19 NKTR moves to S&P 500 from tigerpac 03/09/18 07:40:13 PM
#194   A consolidation at 100 would be good for tigerpac 03/08/18 01:12:34 PM
#193   NKTR buy 74.64 stocktrademan 02/10/18 01:44:36 PM
#192   More money from Blackrock... bullish seppi08162 01/19/18 03:45:46 PM
#191   That’s a tricky call . They have tigerpac 01/10/18 04:21:45 PM
#190   Do we expect the buyout before or after seppi08162 01/10/18 11:59:20 AM
#189   Thanks but I think you posted the wrong presentation. tigerpac 01/10/18 11:42:55 AM
#188   First significant gap and crap this morning. The tigerpac 01/10/18 11:38:02 AM
#186   NKTR +20% .Must be some good stuff being said tigerpac 01/09/18 03:08:39 PM